Molecules 2013, 18
13143
3. Experimental
3.1. General Information
Commercial solvents and reagents were used as received. IR spectra were obtained on a Nicolet
6700 spectrophotometer. 1H-NMR spectra were recorded using a Bruker DPX-400 MHz instrument, at
293 K unless otherwise noted, with the residual peaks of the solvent DMSO-d6 (δ = 2.50) used for
reference. HRMS were obtained on a micromass GCT-TOF instrument. X-Ray crystallographic
analysis was performed with a Rigaku Mercury diffractometer.
3.2. General Procedure for the Synthesis of Pyrazolo[3,4-b]pyridine-6(7H)-ones 4 in Aqueous Media
To a stirred solution of polyethylene glycol (PEG)-400 (5 mL) in water (10 mL), aldehyde 1
(2 mmol), Meldrum’s acid (2, 2 mmol) and 3-methyl-1H-pyrazol-5-amine (3, 2 mmol) were added and
the mixture stirred at 90 °C, until the reaction was complete as indicated by TLC (about 15 min). After
completion of the reaction, the crystalline powder formed was collected by filtration, washed with
water and recrystallized from ethanol to give pure 4. The recovered PEG with water was reused for
further cycles.
3-Methyl-4-p-tolyl-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6(7H)-one (4a). M.p. >300 °C; IR (KBr):
1
3203, 3160 cm−1 (NH), 1650 cm−1 (C=O). H-NMR (DMSO-d6) δ: 1.87 (s, 3H, CH3), 2.26 (s, 3H,
CH3), 2.54 (d, J = 6.0 Hz, 1H, CH), 2.74–2.78 (m, 1H, CH), 4.09 (t, J = 6.4 Hz, 1H, CH), 7.04–7.12
(m, 4H, ArH), 10.27 (s, 1H, NH), 11.79 (s, 1H, NH); HRMS: m/z calcd. for C14H16N3O: 242.12879
(M+H); found 242.12880.
3-Methyl-4-m-tolyl-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6(7H)-one (4b). M.p. >300 °C; IR (KBr):
1
3200, 3150 cm−1 (NH), 1640 cm−1 (C=O). H-NMR (DMSO-d6) δ: 1.83 (s, 3H, CH3), 2.26 (s, 3H,
CH3), 2.54 (d, J = 6.0 Hz, 1H, CH), 2.74–2.79 (m, 1H, CH), 4.09 (t, J = 6.4 Hz, 1H, CH), 7.04–7.12
(m, 4H, ArH), 10.27 (s, 1H, NH), 11.79 (s, 1H, NH); HRMS: m/z calcd. for C14H16N3O: 242.12879
(M+H); found 242.12878.
4-(4-Methoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6(7H)-one (4c). M.p. >300 °C;
IR (KBr): 3180, 3155 cm−1 (NH), 1640 cm−1 (C=O). 1H-NMR (DMSO-d6) δ: 1.83 (s, 3H, CH3), 2.72–2.78
(m, 2H, CH2), 3.73 (s, 3H, OCH3), 4.09 (t, J = 6.4 Hz, 1H, CH), 6.86–6.88 (m, 2H, ArH), 7.07–7.09
(m, 2H, ArH),10.25 (s, 1H, NH), 11.78 (s, 1H, NH); HRMS: m/z calcd. for C14H16N3O2: 258.12370
(M+H); found 258.12369.
4-(3-Methoxyphenyl)-3-methyl-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6(7H)-one (4d). M.p. >300 °C; IR
1
(KBr): 3180, 3150 cm−1 (NH), 1640 cm−1 (C=O). H-NMR (DMSO-d6) δ: 1.85 (s, 3H, CH3), 2.56 (d,
J = 5.6 Hz, 1H, CH), 2.78–2.84 (m, 1H, CH), 3.72 (s, 3H, OCH3), 4.17 (t, J = 6.4 Hz, 1H, CH), 6.73–6.81
(m, 3H, ArH), 7.23 (t, J = 8.0 Hz, 1H, ArH), 10.28 (s, 1H, NH), 11.81 (s, 1H, NH); HRMS: m/z calcd.
for C14H16N3O2: 258.12370 (M+H); found 258.12372.
4-(4-Bromophenyl)-3-methyl-4,5-dihydro-2H-pyrazolo[3,4-b]pyridin-6(7H)-one (4e). M.p. >300 °C;
IR (KBr): 3190, 3160 cm−1 (NH), 1643 cm−1 (C=O). 1H-NMR (DMSO-d6) δ: 1.85 (s, 3H, CH3), 2.56 (d,